| Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
| Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing". Horgen. |
2025-01-09 |
| Innovent Biologics, Inc.. (1/2/25). "Press Release: Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate". San Francisco, CA & Suzhou. |
2025-01-02 |
| Bruker Corporation. (12/20/24). "Press Release: Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility". Zürich. |
2024-12-20 |
| Idorsia Ltd.. (12/20/24). "Press Release: Idorsia Provides Update on the Exclusive Negotiations for the Global Rights to Aprocitentan". Allschwil. |
2024-12-20 |
| BioAge Labs, Inc.. (12/18/24). "Press Release: BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions". Richmond, CA. |
2024-12-18 |
| Evotec SE. (12/11/24). "Press Release: Evotec SE Announces First Projects for LAB eN² Drug Discovery Accelerator with Novo Nordisk". Pratteln. |
2024-12-11 |
| EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million". |
2024-12-11 |
| Formycon AG. (12/9/24). "Press Release: MS Pharma Becomes Partner for the Commercialization of FYB202 / Ustekinumab in the MENA Region". Planegg-Martinsried. |
2024-12-09 |
| Ion Opticks Pty Ltd.. (12/5/24). "Press Release: IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-quality Proteomic Insights". Melbourne. |
2024-12-05 |
| Nouscom S.r.l.. (12/3/24). "Press Release: Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer". Basel. |
2024-12-03 |
| PTC Therapeutics, Inc.. (12/2/24). "Press Release: PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program". Warren, NJ. |
2024-12-02 |
| Eppendorf SE. (12/2/24). "Press Release: Eppendorf SE and DataHow AG Announce Strategic Collaboration to Advance Bioprocess Data Management". Hamburg & Jülich. |
2024-12-02 |
| Idorsia Ltd.. (11/27/24). "Press Release: Idorsia Enters into Exclusive Negotiations for Global Rights to Aprocitentan". Allschwil. |
2024-11-27 |
| Kyan Health AG. (11/26/24). "Press Release: Kyan Health Raises $16.7m to Upgrade Workplace Wellness with AI-powered Preventative Care". |
2024-11-26 |
| Roche. (11/26/24). "Press Release: Roche Enters into a Definitive Agreement to Acquire Poseida Therapeutics, Including Cell Therapy Candidates and Related Platform technologies". Basel. |
2024-11-26 |
| Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
| Novartis AG. (11/21/24). "Press Release: Addressing Unmet Needs for Inherited Neuromuscular Diseases. Novartis Has Acquired Kate Therapeutics to Further Enhance and Strengthen Our Ongoing Efforts to Advance Gene Therapies for Patients". |
2024-11-21 |
| CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA. |
2024-11-14 |
| Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
| CRISPR Therapeutics AG. (11/7/24). "Press Release: CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference". Zug & Boston, MA. |
2024-11-07 |
| CRISPR Therapeutics AG. (11/5/24). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results". Zug & Boston, MA. |
2024-11-05 |
| Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
| Somagenetix AG. (10/8/24). "Press Release: Somagenetix AG Secures CHF 10 Million in Series A Financing to Advance Lentiviral Gene Therapy for Chronic Granulomatous Disease (CGD)". Zurich. |
2024-10-08 |
| Lymphatica Medtech S.A.. (10/8/24). "Press Release: Lymphatica Medtech Closes €17.9m Series B Funding Round to Drive Innovation in Lymphedema Treatment". Lausanne. |
2024-10-08 |
| Ten23 Health AG. (10/7/24). "Press Release: BD and Ten23 Health Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-enabled Prefillable Syringes". Franklin Lakes, NJ & Basel. |
2024-10-07 |
| Ferring Pharmaceuticals S.A.. (10/3/24). "Press Release: Ferring Bolsters Global Gene Therapy Supply Chain with European Manufacturing Facility". Saint-Prex. |
2024-10-03 |
| Nagi Bioscience S.A.. (9/19/24). "Press Release: Nagi Bioscience Launches Exclusive Priority Access Program, Bringing Revolutionary SydLab One Platform to Five Leading academic Labs for C. elegans Research". Saint-Sulpice. |
2024-09-19 |
| ImmunOs Therapeutics AG. (9/17/24). "Press Release: ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base". |
2024-09-17 |
| Roche. (9/10/24). "Press Release: Roche Opens Pharma Research and Development Center in Basel to Accelerate Scientific Innovation". Basel. |
2024-09-10 |
| Epsilogen Ltd.. (9/9/24). "Press Release: Epsilogen Completes £12.5 Million Series B Financing Expansion". London. |
2024-09-09 |
| Genedata AG. (9/5/24). "Press Release: Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics". Basel. |
2024-09-05 |
| Haya Therapeutics SA. (9/4/24). "Press Release: Haya Therapeutics Announces Collaboration with Lilly to Discover Novel Regulatory Genome Targets for Obesity and Related Metabolic Conditions Using Proprietary RNA Platform". Lausanne & San Diego, CA. |
2024-09-04 |
| Alentis Therapeutics AG. (9/3/24). "Press Release: Alentis Appoints Jonathan Freve CFO". Basel. |
2024-09-03 |
| Boehringer Ingelheim. (9/3/24). "Press Release: Boehringer Ingelheim Acquires Saiba Animal Health, Adding Innovative Technology Platform to Its Pet Therapeutics R&D Portfolio". Ingelheim. |
2024-09-03 |
| Lindy Biosciences Inc.. (8/28/24). "Press Release: Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation". Raleigh, NC. |
2024-08-28 |
| Novartis AG. (8/22/24). "Press Release: Novartis Employs Creative Deal Structure to Establish Borealis Biosciences – Divests Legacy Chinook Site, Invests to Form New Company and Engages in R&D collaboration". |
2024-08-22 |
| Vandria S.A.. (8/21/24). "Press Release: Hevolution Foundation and Dolby Family Ventures Join Vandria’s 2nd Series A Closing, Bringing the Total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development". Lausann |
2024-08-21 |
| Genedata AG. (8/19/24). "Press Release: Genedata Joins Danaher Corporation". Basel. |
2024-08-19 |
| PolyPeptide Group AG. (8/8/24). "Press Release: PolyPeptide Appoints Chief Commercial Officer". Baar. |
2024-08-08 |
| CRISPR Therapeutics AG. (8/5/24). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results". Zug & Boston, MA. |
2024-08-05 |
| Valneva S.E.. (8/1/24). "Press Release: Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’s Most Clinically Advanced Tetravalent Shigella Vaccine Candidate". Saint-Herblain & Schlieren. |
2024-08-01 |
| Venture Kick. (7/25/24). "Press Release: Amporin Pharmaceuticals Receives the CHF 150,000 Kick to Develop a Breakthrough Class of Small-molecule Drugs". |
2024-07-25 |
| Immunic, Inc.. (7/24/24). "Press Release: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec". New York, NY. |
2024-07-24 |
| Dren Bio, Inc.. (7/24/24). "Press Release: Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer". Foster City, CA. |
2024-07-24 |
| Regenosca SA. (7/22/24). "Press Release: Regenosca Closes CHF 1M Pre-seed Round to Demonstrate Endoscopic Delivery of TissueSpan Implants". Lausanne. |
2024-07-22 |
| Addex Therapeutics S.A.. (7/22/24). "Press Release: Addex’s Partner Discontinues ADX71149 Development in Epilepsy". Geneva. |
2024-07-22 |
| Haya Therapeutics SA. (7/18/24). "Press Release: Haya Therapeutics Appoints Former Roche Global Head of Operations Eric Adam, Ph.D. as Chief Operating Officer". Lausanne & San Diego, CA. |
2024-07-18 |
| Nouscom AG. (7/17/24). "Press Release: Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice President, Technical and CMC Development". Basel. |
2024-07-17 |
| Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. |
2024-07-16 |
| Evotec SE. (7/8/24). "Press Release: Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz". Hamburg & Seattle, WA. |
2024-07-08 |
| Venture Kick. (7/1/24). "Press Release: ETH Zurich Spin-off Enantios Secures Over CHF 1.8M in Seed Funding to Innovate Complex Molecule Characterization". |
2024-07-01 |
| Haya Therapeutics SA. (7/1/24). "Press Release: Haya Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award". Lausanne & San Diego, CA. |
2024-07-01 |
| Partners Group AG. (7/1/24). "Press Release: Partners Group to Acquire Majority Stake in FairJourney Biologics, a Leading Antibody Discovery Contract Research Organization". Baar ZG. |
2024-07-01 |
| Merck KGaA. (6/24/24). "Press Release: Merck Provides Update on Xevinapant Program in Locally Advanced Head and Neck Cancer [ Not intended for UK-, US- or Canada-based media ]". Darmstadt. |
2024-06-24 |
| Tecan Group Ltd.. (6/24/24). "Press Release: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division". Männedorf. |
2024-06-24 |
| Allecra Therapeutics GmbH. (6/24/24). "Press Release: Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic Exblifeb in Gulf Cooperation Council countries and South Africa". Saint-Louis, Weil am Rhein |
2024-06-24 |
| DataHow AG. (6/21/24). "Press Release: DataHow Secures Series A investment for Its AI Bioprocessing Solutions". |
2024-06-21 |
| Santhera Pharmaceuticals Holding AG. (6/18/24). "Press Release: Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund Operations to Cash Flow Break-Even (Ad hoc announcement pursuant to Art. 53 LR)". Pratteln. |
2024-06-18 |
| NXI Therapeutics AG. (6/18/24). "Press Release: NXI Therapeutics Extends Pre-Seed Financing to CHF 3.5 Million in Run-up to Larger Seed Financing". Basel. |
2024-06-18 |
| Bright Peak Therapeutics AG. (6/11/24). "Press Release: Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials". Basel & San Diego, CA. |
2024-06-11 |
| MorphoSys AG. (6/6/24). "Press Release: Arkadius Pichota and Lukas Gilgen Appointed to Management Board of MorphoSys AG Replacing the Current CEO and CFO (Ad hoc)". Planegg. |
2024-06-06 |
| Seres Therapeutics, Inc.. (6/6/24). "Press Release: Seres Therapeutics Enters into Memorandum of Understanding for Vowst Asset Sale to Nestlé Health Science". Cambridge, MA. |
2024-06-06 |
| Nagi Bioscience S.A.. (5/30/24). "Press Release: Nagi Bioscience Makes a Strong Debut at BIO International as Part of the Innosuisse Cohort for the Swiss Pavilion". Saint-Sulpice. |
2024-05-30 |
| ExpressionEdits Ltd.. (5/29/24). "Press Release: ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology". Cambridge. |
2024-05-29 |
| Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire Its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H |
2024-05-28 |
| SixPeaks Bio AG. (5/22/24). "Press Release: SixPeaks Bio AG Debuts With $110 Million in Funding". Basel. |
2024-05-22 |
| Limula SA. (5/21/24). "Press Release: Limula Raises CHF 6.2 Million in Oversubscribed Seed Round to Develop Automated Cell and Gene Therapy Manufacturing Platform". Lausanne. |
2024-05-21 |
| Cutiss AG. (5/17/24). "Press Release: Cutiss Announces First Closing of CHF 25M in Series C Funding Round". Switzerland. |
2024-05-17 |
| Cell and Gene Therapy Catapult, The. (5/15/24). "Press Release: UK and Swiss Consortium to Apply Innovative Technologies to Lower Cost of Manufacturing Cell and Gene Therapies". London & Zurich. |
2024-05-15 |
| ERS Genomics Ltd.. (5/13/24). "Press Release: ERS Genomics Appoints John E Milad as Chief Executive Officer". Stockholm. |
2024-05-13 |
| AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne. |
2024-05-13 |
| BioVersys AG. (5/7/24). "Press Release: BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million". Basel. |
2024-05-07 |
| Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren. |
2024-05-07 |
| Atopia Therapeutics SA. (5/7/24). "Press Release: Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update". Geneva. |
2024-05-07 |
| ADC Therapeutics S.A.. (5/6/24). "Press Release: ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants". Lausanne. |
2024-05-06 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd.. (5/6/24). "Press Release: Biocytogen Enters into Evaluation and Potential Licensing Agreement with BioCopy for TCR-mimic Antibodies". Beijing. |
2024-05-06 |
| Novartis AG. (5/2/24). "Press Release: Novartis Enters Agreement to Acquire Mariana Oncology, Strengthening Radioligand Therapy Pipeline". Basel. |
2024-05-02 |
| Mariana Oncology Inc.. (5/2/24). "Press Release: Mariana Oncology to Be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer". Watertown, MA. |
2024-05-02 |
| PeptiDream Inc.. (4/30/24). "Press Release: PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis". Kanagawa. |
2024-04-30 |
| Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva. |
2024-04-29 |
| Basel Area Business & Innovation. (4/26/24). "Press Release: Johnson & Johnson Opens Innovation Hub in Allschwil". |
2024-04-26 |
| BioLizard N.V.. (4/18/24). "Press Release: BioLizard Appoints Matthew Hall as Director of Business Development". Lausanne & Ghent. |
2024-04-18 |
| Isospec Analytics SA. (4/16/24). "Press Release: Isospec Analytics Raises $1.9m as It Introduces Breakthrough Technology to Rapidly Identify Unknown Molecules at Scale". Lausanne. |
2024-04-16 |
| FundaMental Pharma GmbH. (4/11/24). "Press Release: FundaMental Pharma Appoints Dr. Dirk Beher as Chief Executive Officer". Heidelberg. |
2024-04-11 |
| Idorsia Ltd.. (4/11/24). "Press Release: Idorsia Takes Steps to Address Short-term Liquidity Needs". Allschwil. |
2024-04-11 |
| BioCopy AG. (4/9/24). "Press Release: BioCopy Expands Corporate Portfolio with Acquisition of Perspix Biotech GmbH". Basel. |
2024-04-09 |
| Biognosys AG. (4/4/24). "Press Release: Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research". Zürich & Fremont, CA. |
2024-04-04 |
| Basilea Pharmaceutica Ltd.. (4/4/24). "Press Release: Basilea Announces US FDA Approval of Antibiotic Zevtara (ceftobiprole medocaril) for Three Indications". Allschwil. |
2024-04-04 |
| HealthTech For Care. (4/3/24). "Press Release: HealthTech For Care Launches Its European Patient Observatory to Accelerate Healthcare Equality in Europe". Paris. |
2024-04-03 |
| Addex Therapeutics S.A.. (4/3/24). "Press Release: Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders". Geneva & New York, NY. |
2024-04-03 |
| Lonza Group AG. (4/2/24). "Press Release: Wolfgang Wienand, Currently CEO of Swiss CDMO Siegfried Holding AG, Will Become Chief Executive Officer of Lonza in the Summer of 2024". Basel. |
2024-04-02 |
| Venturelab AG. (3/27/24). "Press Release: Venture Leaders Biotech 2024 – 10 Innovative Startups Selected for the Boston Roadshow". |
2024-03-27 |
| Hemotune AG. (3/25/24). "Press Release: Hemotune Raises CHF 14 Million Series B2 Funding for Clinical Trials with the HemoSystem". Schlieren. |
2024-03-25 |
| Volumina Medical SA. (3/25/24). "Press Release: Volumina Medical Secures USD 21 Million Funding to Continue Its Clinical Program after Having Obtained Promising First in Human Data". Epalinges. |
2024-03-25 |
| Angelini Ventures S.p.A.. (3/21/24). "Press Release: Angelini Ventures Invests into Extended €75.8 Million ($82 Mmillion) Series C Financing Round for Nouscom". Rome. |
2024-03-21 |
| Idorsia Ltd.. (3/20/24). "Press Release: US FDA Approves Idorsia’s Once-daily Tryvio (aprocitentan) – the First and Only Endothelin Receptor Antagonist for the Treatment of High Blood Pressure Not Adequately Controlled in Combination with other Antihyper |
2024-03-20 |
| BioNTech SE. (3/20/24). "Press Release: BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer". Mainz. |
2024-03-20 |
| Lonza Group AG. (3/20/24). "Press Release: Lonza Signs Agreement to Acquire Large-scale Biologics Site in Vacaville (US) from Roche". Basel. |
2024-03-20 |
| Idorsia Ltd.. (3/18/24). "Press Release: Idorsia and Viatris Successfully Close the Transaction for the Global Research and Development Collaboration". Allschwil. |
2024-03-18 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
